Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Passage of intravenous immunoglobulin and interaction with the CNS.

× No keyword cloud information.

39 in total

1. Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate.

Authors: D Triguero; J L Buciak; W M Pardridge
Journal: J Pharmacol Exp Ther Date: 1991-07-01 Impact factor: 4.030

Review 2. Use of intravenous immunoglobulin in various medical conditions. A Japanese experience.

Authors: T Abe; K Kawasugi
Journal: Cancer Date: 1991-09-15 Impact factor: 6.860

Review 3. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.

Authors: S V Kaveri; G Dietrich; V Hurez; M D Kazatchkine
Journal: Clin Exp Immunol Date: 1991-11 Impact factor: 4.330

4. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

Authors: P A van Doorn; A Brand; P F Strengers; J Meulstee; M Vermeulen
Journal: Neurology Date: 1990-02 Impact factor: 9.910

5. Protein size and cerebrospinal fluid composition.

Authors: K Felgenhauer
Journal: Klin Wochenschr Date: 1974-12-15

6. Fc receptor for IgG (FcR) on rat microglia.

Authors: C Vedeler; E Ulvestad; I Grundt; G Conti; H Nyland; R Matre; D Pleasure
Journal: J Neuroimmunol Date: 1994-01 Impact factor: 3.478

7. Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin.

Authors: Y Kuroda; H Takashima; A Ikeda; C Endo; R Neshige; R Kakigi; H Shibasaki
Journal: J Neurol Date: 1991-09 Impact factor: 4.849

8. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.

Authors: K G Warren; I Catz
Journal: J Neurol Sci Date: 1991-05 Impact factor: 3.181

9. Binding sites for immune components in human choroid plexus.

Authors: N S Peress; V A Roxburgh; M C Gelfand
Journal: Arthritis Rheum Date: 1981-03

10. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.

Authors: W W Tourtellotte; A R Potvin; J O Fleming; K N Murthy; J Levy; K Syndulko; J H Potvin
Journal: Neurology Date: 1980-03 Impact factor: 9.910

6 in total

Review 1. Adverse effects of intravenous immunoglobulin therapy.

Authors: U E Nydegger; M Sturzenegger
Journal: Drug Saf Date: 1999-09 Impact factor: 5.606

Review 2. Intravenous immunoglobulin and multiple sclerosis.

Authors: Anat Achiron; Shmuel Miron
Journal: Clin Rev Allergy Immunol Date: 2005-12 Impact factor: 8.667

3. Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

Authors: Dennis P Han
Journal: Trans Am Ophthalmol Soc Date: 2004

4. Monomeric IgG is neuroprotective via enhancing microglial recycling endocytosis and TNF-alpha.

Authors: Raymond E Hulse; Wade G Swenson; Phillip E Kunkler; David M White; Richard P Kraig
Journal: J Neurosci Date: 2008-11-19 Impact factor: 6.167

5. Dose-dependent inhibition of demyelination and microglia activation by IVIG.

Authors: Meike Winter; Christine Baksmeier; Julia Steckel; Sumanta Barman; Manish Malviya; Melanie Harrer-Kuster; Hans-Peter Hartung; Norbert Goebels
Journal: Ann Clin Transl Neurol Date: 2016-09-23 Impact factor: 4.511

6. Nano Differential Scanning Fluorimetry-Based Thermal Stability Screening and Optimal Buffer Selection for Immunoglobulin G.

Authors: Soo Hyun Kim; Han Ju Yoo; Eun Ji Park; Dong Hee Na
Journal: Pharmaceuticals (Basel) Date: 2021-12-25

6 in total